The Comparison of Inspiratory Muscle Training Effectiveness in COPD Patients with Obesity and Normal Weight

ORIGINAL ARTICLE
Evgeniy S. Ovsyannikov, Sergey N. Avdeev, Andrey V. Budnevsky, Yanina S. Shkatova, Ekaterina M. Simenskaia, Aleksandr A. Popov

 
International Journal of Biomedicine. 2019;9(4):304-307.
DOI: 10.21103/Article9(4)_OA6
Originally published December 15, 2019  

Abstract: 

The objective of this study was to compare the effectiveness of inspiratory muscle training in COPD patients with obesity and patients with normal body weight.
Materials and Methods: The study involved 2 groups of patients with COPD (clinical Group D) similar in spirometric parameters with signs of airflow limitation on spirometry (FEV1<50% of predicted, a post-bronchodilator FEV1/FVC ratio<70% of predicted). Group 1 consisted of 45 obese COPD patients (BMI>30kg/m2). Group 2 included 44 COPD patients with normal body weight (BMI from 18.5kg/m2 to 24.9kg/m2). The groups were comparable in age, gender, severity of bronchial obstruction, concomitant pathology, and drug therapy. All patients underwent IMT for 8 weeks. Breathe-Link Live Feedback Software was used to evaluate such parameter as SI (Strength Index), PIF (Peak Inspiratory Flow), Average Pressure, Average Power, Average Flow, Average Volume for the entire sessions were estimated. At the baseline and after 8 weeks all patients underwent an assessment of the lung function using spirometry (including FVC, FEV1), and the severity of dyspnea using the mMRC questionnaire (The Modified Medical Research Council).
Results: A comparative analysis of the estimated parameters of training sessions showed a significant increase in SI, PIF, Average Power, and Average Flow in patients of Group 1. In patients of Group 2, we found only a tendency to be increased in these parameters, with the exception of Average Flow. A statistically significant increase in the FEV1 and FVC parameters  was observed only in Group 1. Statistical analysis showed a close correlation between the SI and the severity of dyspnea on the mMRC scale (r=-0.52, P<0.05) in Group 1.
Conclusion: The results of our study indicate a positive effect of IMT in patients with COPD, and a greater effect in patients with obesity than in those with normal body weight. Clinically, an improvement in the IMT parameters was expressed in a decrease in dyspnea and an improvement in spirometric indicators.

Keywords: 
chronic obstructive pulmonary disease • obesity • inspiratory muscle training
References: 
  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD. Avail­able at: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-rev.... Accessed 20 January 2019.
  2. Aisanov Z, Avdeev S, Arkhipov V, Belevskiy A, Chuchalin A, Leshchenko I, et al. Russian guidelines for the management of COPD: algorithm of pharmacologic treatment. Int J Chron Obstruct Pulmon Dis. 2018;13:183-187. doi: 10.2147/COPD.S153770.
  3. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, et al.; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15-62. doi: 10.1164/rccm.201402-0373ST.
  4. Rochester DF, Braun NM, Arora NS. Respiratory muscle strength in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1979;119(2 Pt 2):151-4.
  5. Similowski T, Yan S, Gauthier AP, Macklem PT, Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med. 1991;325(13):917-23.
  6. Di Francia M, Barbier D, Mege JL, Orehek J.Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;150(5 Pt 1):1453-5.
  7. Gea J, Pascual S, Casadevall C, Orozco-Levi M, Barreiro E. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis. 2015;7(10):E418-38. doi: 10.3978/j.issn.2072-1439.2015.08.04.
  8. Barreiro E, Gea J. Respiratory and Limb Muscle Dysfunction in COPD. COPD. 2015;12(4):413-26. doi: 10.3109/15412555.2014.974737.
  9. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;150(5 Pt 1):1453-5.
  10.  Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med. 1996;154(4 Pt 1):1055-60.
  11. A Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483. doi: 10.1371/journal.pone.0037483.
  12. Remels AH, Gosker HR, Langen RC, Schols AM. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol (1985). 2013;114(9):1253-62. doi: 10.1152/japplphysiol.00790.2012.
  13. Budnevsky AV, Ovsyannikov ES, Labzhania NB. [Chronic obstructive pulmonary disease concurrent with metabolic syndrome: Pathophysiological and clinical features]. Ter Arkh. 2017;89(1):123-127. doi: 10.17116/terarkh2017891123-127. [Article in Russian].
  14. Kozhevnikova SA, Budnevsky AV, Ovsyannikov ES, Belov VN. Particularity of the clinical course and quality of life of patients with chronic obstrustive pulmonary disease on the background of the metabolic syndrome. Medical News of the North Caucasus. 2017;12(1):20-23. doi: 10.14300/mnnc.2017.12006. [Article in Russian].
  15. Budnevsky AV, Isaeva YV, Malysh EY, Kozhevnikova SA. [Pulmonary rehabilitation as an effective method for optimizing therapeutic and preventive measures in patients with chronic obstructive pulmonary disease concurrent with metabolic syndrome]. Ter Arkh. 2016;88(8):25-29. doi: 10.17116/terarkh201688825-29. [Article in Russian].
  16. Geddes EL, O’Brien K, Reid WD, Brooks D, Crowe J. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir Med. 2008;102(12):1715-29. doi: 10.1016/j.rmed.2008.07.005
  17. Minahan C, Sheehan B, Doutreband R, Kirkwood T, Reeves D, Cross T. Repeated-sprint cycling does not induce respiratory muscle fatigue in active adults: measurements from the powerbreathe® inspiratory muscle trainer. J Sport Sci Med. 2015;14(1):233-8
  18. Silva PE, de Carvalho KL, Frazão M, Maldaner V, Daniel CR, Gomes-Neto M. Assessment of Maximum Dynamic Inspiratory Pressure. Respir Care. 2018; 63(10):1231-1238. doi: 10.4187/respcare.06058.
  19. Villiot-Danger JC, Villiot-Danger E, Borel JC, Pépin JL, Wuyam B, Vergès S. Respiratory muscle endurance training in obese patients. Int J Obes (Lond). 2011;35(5):692-9. doi: 10.1038/ijo.2010.191.
  20. Puhan MA, Busching G, Schunemann HJ, VanOort E, Zaugg C, Frey M. Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2006;145:816-25. doi: 10.7326/0003-4819-145-11-200612050-00006
  21. Morris T, Sumners DP, Green DA. Inspiratory high frequency airway oscillation attenuates resistive loaded dyspnea and modulates respiratory function in young healthy individuals. PLoS One. 2014;9(3):e91291. doi: 10.1371/journal.pone.0091291.
  22. Sturdy G, Hillman D, Green D, Jenkins SC, Cecins N, Eastwood P. Feasibility of high-intensity, interval-based respiratory muscle training in COPD. Chest. 2003;123(1):142-50. doi: 10.1378/chest.123.1.142

Download Article
Received October 18, 2019.
Accepted November 15, 2019.
©2019 International Medical Research and Development Corporation.